EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens

Weijie Wang, Xiaoli Zhu, Huan Luo, Zheng Wang, Anjin Hong, Jie Zeng, Li Li, Dai Wang, Xianming Deng, Xilin Zhao iD

Microbiology Spectrum · 14.02.2023 · 11 (1)

DOI: 10.1128/spectrum.03790-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 14.02.2023. Verfasst von Weijie Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Laboratory Medicine, School of Public Health, Xiamen Universit…. Hauptthemen laut MEDLINE: Anti-Infective Agents, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Fundamental Research Funds for the Central Universities of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As antimicrobial resistance continues to increase, options for effectively treating multidrug-resistant (MDR) Gram-negative infections are declining. Finding ways to enhance the lethality of old agents that have unique molecular targets is important because developing new antimicrobials is becoming increasingly difficult.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsCarbapenem-Resistant EnterobacteriaceaeHumansMiceAnimalsEscherichia coliDoxycyclineAnti-Bacterial AgentsKlebsiella pneumoniaeGram-Negative BacteriaMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

MIC distributionbicyclomycinlethal synergymultidrug-resistant Gram-negative bacteriamurine model of infection

Substanzen

DoxycyclineAnti-Bacterial AgentsAnti-Infective AgentsbicozamycinBridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
  • State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products, Xiamen University, Xiamen, Fujian, China.

ORCID-Profile: Xilin Zhao

Förderung

  • Medical Research Council
  • Fundamental Research Funds for the Central Universities of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, W., Zhu, X., Luo, H., Wang, Z., Hong, A., Zeng, J., Li, L., Wang, D., Deng, X., & Zhao, X. (2023). Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens. Microbiology Spectrum, 11(1). https://doi.org/10.1128/spectrum.03790-22

Vancouver

Wang W, Zhu X, Luo H, Wang Z, Hong A, Zeng J, et al. Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens. Microbiology Spectrum. 2023;11(1). doi:10.1128/spectrum.03790-22

BibTeX
@article{Wang2023,
  author = {Wang, Weijie and Zhu, Xiaoli and Luo, Huan and Wang, Zheng and Hong, Anjin and Zeng, Jie and Li, Li and Wang, Dai and Deng, Xianming and Zhao, Xilin},
  title = {Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {1},
  doi = {10.1128/spectrum.03790-22}
}
Kostenlos starten →